ROCHESTER, N.Y., Oct. 28 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, today announced that on November 4, 2008 it will release its 2008 third quarter financial results for the period ended September 30, 2008. The company will host a conference call to discuss these results on Wednesday, November 5, 2008 at 11:00 a.m. EST.
VirtualScopics' President and Chief Executive Officer, Jeff Markin, and Chief Business and Financial Officer, Molly Henderson, will provide a business update and discuss the company's results for the third quarter 2008, during the conference call.
Interested participants should call 877-407-0778 when calling within the United States or 201-689-8565 when calling internationally. There will be a playback available until December 5, 2008. To listen to the playback, please call 877-660-6853 when calling within the United States or 201-612-7415 when calling internationally. For the replay, please use account number: 286, conference ID number: 301146.
This call is being Web cast by Vcall and can be accessed at http://www.virtualscopics.com . The Web cast will be available for 30 days after the call.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit http://www.virtualscopics.com .
The statements contained in this press release that are not purely
historical are forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended, and are intended to be covered by the
safe harbors created thereby. These forward-looking statements include, but
are not limited to, statements regarding the backlog and new customer
awards in 2008 and/or statements preceded by, followed by or that include
the words "believes," "could," "expects," "anticipates," "estimates,"
"intends," "plans," "projects," "seeks," or similar expressions.
Forward-looking statements deal with the Company's current plans,
intentions, beliefs and expectations. Investors are cautioned that all
forward-looking statements involve risks and uncertainties that could cause
actual results to differ materially from those in the forward-looking
statements. Many of these risks and uncertainties are discussed in the
Company's Annual Report on Form 10-KSB for the fiscal year ended December
31, 2007 filed with the Securities and Exchange Commission (the "SEC"), and
in any subsequent reports filed with the SEC, all of which are available at
the SEC's website at http://www.sec.gov . These include without limitation: the
risk of cancellation or delay of customer contracts or specifically as it
relates to awards of contracts currently under negotiation, the risk that
they may not get signed. Other risks include the company's dependence on
its largest customers and risks of contract performance. All
forward-looking statements speak only as of the date of this press release
and the Company undertakes no obligation to update such forward-looking
Chief Business and Financial Officer
500 Linden Oaks
Rochester, New York 14625
|SOURCE VirtualScopics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved